One striking exception to this is the recent discovery that a point mutation in human mitofusin 2 (MFN2) produces profound adipose tissue dysfunction, non-alcoholic fatty liver disease, insulin resistance and type 2 diabetes [5–7]. This evidence concerns the gene MFN2 and Insulin resistance.